SVF
Level D· Preclinical EvidenceLaboratory Study

Three-Dimensional Meltblowing as a High-Speed Fabrication Process for Tendon Tissue Engineered Scaffolds.

Umemori K., Pourdeyhimi B., Little D.

Laboratory Study on Tendon Injury, Rotator Cuff, Scar, published in Bioprinting (2025) — summary generated from the PubMed abstract.

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Bioprinting (2025)
Country
Netherlands
Reported sample size
—
PMID
40322756
DOI
10.1016/j.bprint.2025.e00409

Abstract (original English)

Rotator cuff tears continue to be a critical challenge for successful repair due to the formation of fibrotic scar tissue during healing. Tendon tissue engineering seeks to improve these outcomes using nonwoven fabrication methods to produce biomimetic scaffolds. Meltblowing has several advantages over other nonwoven approaches including non-toxic fabrication processes and being high-throughput and economical, while accurately producing fiber diameters comparable to native tendon microstructure. Recently 3D meltblowing (3DMB) introduced high degrees of tunability to the core process, allowing for production of highly aligned fiber mats at anatomically relevant dimensions. Here, we evaluated 3DMB scaffolds fabricated using poly-L-lactic acid (PLA) and poly-ε-caprolactone (PCL) by characterizing scaffold properties before and after culture with human adipose stem cells (hASCs). Mechanical and fiber characterization of 3DMB scaffolds closely resembled tendon microarchitecture by exhibiting high fiber alignment and mechanical anisotropy. hASC-seeded 3DMB scaffolds after 28 days of culture proliferated and deposited aligned tendon-like extracellular matrix. Furthermore, cell culture enhanced the Young's modulus of PLA 3DMB scaffolds and improved yield stress, yield stretch, and stiffness of both 3DMB scaffolds. The proteome of cultured 3DMB scaffolds increased expression of tendon-r

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence comes from animal or laboratory studies and has not been confirmed in humans.

How we grade evidence
ShoulderTendon InjuryRotator CuffScar
View on PubMedDOI

Related research